Idea principal
In health care workers wearing an Apple Watch, the circadian amplitude of an HRV measure (SDNN) differed between people with and without COVID-19 (P=.006) and in the 7 days around diagnosis versus uninfected periods (P=.01). The abstract gives no participant numbers or accuracy, so its value as an individual warning is unproven.
Study design
Artículo de investigación
Reading basis
Published abstract
Reading focus
Design & applicability
Esta explicación editorial está disponible en inglés, chino simplificado y chino tradicional. Esta interfaz muestra la lectura en inglés.
Pregunta de investigación
Infection can alter the autonomic nervous system, which shows up as changes in heart rate variability (HRV), sometimes before symptoms are clinically recognized. The authors tested whether HRV from a commercial smartwatch could identify COVID-19 and its symptoms, and whether changes appear ahead of diagnosis.
Población y método
Prospective observational study of health care workers in the Mount Sinai Health System using the custom Warrior Watch Study app on their smartphones. Participants wore an Apple Watch throughout follow-up, which measured HRV, and completed daily surveys about infection and symptoms. A mixed-effect cosinor model assessed the circadian pattern of SDNN (the standard deviation of the interbeat interval of normal sinus beats), comparing infected with uninfected people and infected with uninfected time periods. The abstract does not report the number of participants.
Resultados
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1The mean amplitude of the daily (circadian) pattern of SDNN differed between people with and without COVID-19 (P=.006).
- 2The mean amplitude differed in the 7 days before and the 7 days after a COVID-19 diagnosis compared with uninfected periods (P=.01).
- 3The mean and amplitude of the SDNN pattern changed on the first day of reporting a COVID-19-related symptom compared with all other symptom-free days (P=.01).
- 4The authors conclude that HRV changes were seen before diagnosis by nasal swab PCR testing.
Límites e incertidumbre
- 1The abstract reports no participant numbers, effect sizes or direction of change, so the size and practical meaning of the differences are unclear.
- 2Results are group-level P values; they do not give sensitivity, specificity or false-alarm rates for flagging infection in one person.
- 3Participants were health care workers in one health system, who may differ from the general public in exposure, stress and sleep.
- 4Many things besides infection alter HRV, such as sleep loss, alcohol, stress and training, so the changes are not specific to COVID-19.
Relevancia práctica
A smartwatch HRV pattern may shift around the time of infection, which is interesting, but it cannot tell you that you have COVID-19. If you feel unwell or are exposed, use a test and follow medical advice rather than relying on a watch.
Tus datos
Overnight HRV trends from a watch can show when your body is under strain. Use the same device and wear it the same way, and judge deviations from your own multi-week baseline rather than a single night; a sustained dip along with symptoms is a reason to rest and test, not a diagnosis.
Cómo interpretar la evidencia
The index does not establish a precise design. Read the methods before making causal claims; check population, comparator, outcomes and uncertainty in the source.
Resumen estructurado de los autores English
El resumen original en inglés se reproduce con atribución bajo la licencia indicada. Es una fuente, no una interpretación de MoveVitals. El análisis preparado figura arriba; verifica los resultados importantes en la fuente.
Background
Changes in autonomic nervous system function, characterized by heart rate variability (HRV), have been associated with infection and observed prior to its clinical identification.
Objective
We performed an evaluation of HRV collected by a wearable device to identify and predict COVID-19 and its related symptoms.
Methods
Health care workers in the Mount Sinai Health System were prospectively followed in an ongoing observational study using the custom Warrior Watch Study app, which was downloaded to their smartphones. Participants wore an Apple Watch for the duration of the study, measuring HRV throughout the follow-up period. Surveys assessing infection and symptom-related questions were obtained daily.
Results
Using a mixed-effect cosinor model, the mean amplitude of the circadian pattern of the standard deviation of the interbeat interval of normal sinus beats (SDNN), an HRV metric, differed between subjects with and without COVID-19 (P=.006). The mean amplitude of this circadian pattern differed between individuals during the 7 days before and the 7 days after a COVID-19 diagnosis compared to this metric during uninfected time periods (P=.01). Significant changes in the mean and amplitude of the circadian pattern of the SDNN was observed between the first day of reporting a COVID-19-related symptom compared to all other symptom-free days (P=.01).
Conclusions
Longitudinally collected HRV metrics from a commonly worn commercial wearable device (Apple Watch) can predict the diagnosis of COVID-19 and identify COVID-19-related symptoms. Prior to the diagnosis of COVID-19 by nasal swab polymerase chain reaction testing, significant changes in HRV were observed, demonstrating the predictive ability of this metric to identify COVID-19 infection.
Fuentes y atribución
Use of Physiological Data From a Wearable Device to Identify SARS-CoV-2 Infection and Symptoms and Predict COVID-19 Diagnosis: Observational Study.
Hirten RP, Danieletto M, Tomalin L, Choi KH, Zweig M, Golden E, Kaur S, Helmus D, Biello A, Pyzik R, Charney A, Miotto R, Glicksberg BS, Levin M, Nabeel I, Aberg J, Reich D, Charney D, Bottinger EP, Keefer L, Suarez-Farinas M, Nadkarni GN, Fayad ZA.
Journal of medical Internet research · 2021-02-22
DOI: 10.2196/26107 ↗PubMed · 33529156 ↗Europe PMC · Licencia registrada: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interpretación editorial de MoveVitals · contenido educativo · sin revisión clínica individual registrada
Fuentes verificadas 2026-11-01
Guías prácticas
Leer en contexto
Activity–stroke and heart attack curves differ by accelerometer processing method
Among 90,237 UK Biobank adults free of cardiovascular disease at baseline, followed until December 2022 for 1,298 strokes and 2,031 myocardial infarctions, the shape of the link between moderate-vigorous physical activity (MVPA) and each outcome depended on how the accelerometer data were processed. For stroke, hazard fell in a straight line only with the machine-learning metric; for myocardial infarction, two metrics gave a curved decline and activity counts a straight one. The abstract gives no hazard ratios, so it shows that methods disagree, not which one is right, and the findings are observational associations.
Preventive Medicine
Smartwatch data as forensic evidence: heart rate is best validated, the rest uneven
A systematic review and meta-analysis of studies on smartwatches from four major brands, framed around digital forensics, found that heart rate was both the most studied and the most accurate measure. Step count, distance, energy expenditure, activity classification and sleep were less consistently validated, and results varied by brand, protocol and reporting. The abstract gives no pooled numbers, and most studies were run in healthy people in laboratories, so it cannot say how a particular watch performs for a particular person in daily life.
Forensic Science International
Activity trackers: about 1,800 more steps a day, but small effects on other outcomes
An umbrella review of 39 systematic reviews and meta-analyses, covering 163,992 participants, found that activity trackers were associated with more physical activity (SMD 0.3–0.6), equating to about 1,800 extra steps and 40 minutes more walking per day, and with a bodyweight reduction of about 1 kg. Effects on blood pressure, cholesterol, glycosylated haemoglobin, quality of life and pain were typically small and often non-significant. The abstract does not say what else came with the trackers in these programs or how much the reviews overlap, so the gains cannot be credited to the device alone.
The Lancet Digital Health
Seven sleep trackers: good at spotting sleep, weak on wake and sleep stages
In a sleep laboratory, 34 healthy young adults wore a subset of seven consumer sleep trackers for three nights. Against polysomnography every device detected sleep very well (sensitivity 0.93 or higher) but caught wake poorly (specificity 0.18–0.54), and five of the seven matched or beat research actigraphy (specificity 0.39). Sleep-stage estimates were inconsistent, and the participants were healthy adults aged 18 to 35 in a fixed 8-hour bed window, with each device tested in only 11 to 20 of them, so the results say little about people with sleep problems.
Sleep

